Search

Your search keyword '"Pucci, Giacomo"' showing total 16 results
Start Over Author "Pucci, Giacomo" Publication Year Range This year
16 results on '"Pucci, Giacomo"'

4. Contributors

Author

Agabiti-Rosei, Claudia, primary, Agabiti-Rosei, Enrico, additional, Agnoletti, Davide, additional, Alastruey, Jordi, additional, AlGhatrif, Majd, additional, Almada, Horacio, additional, Ángela, Sardella, additional, Argyris, Antonios, additional, Aristizabal, Dagnovar, additional, Armeni, Eleni, additional, Avolio, Alberto, additional, Badariene, Jolita, additional, Badhwar, Smriti, additional, Barbosa, Eduardo Costa Duarte, additional, Barroso, Weimar Kunz Sebba, additional, Bascetin, Rümeyza, additional, Baynard, Tracy, additional, Becerra, Carlos Ramos, additional, Bennett, Nadia, additional, Bianchini, Elisabetta, additional, Bohn, Lucimere, additional, Borghi, Claudio, additional, Bortolotto, Luiz Aparecido, additional, Boutouyrie, Pierre, additional, Bruno, Rosa Maria, additional, Burnier, Michel, additional, Butlin, Mark, additional, Calabria, Fabiana, additional, Camafort, Miguel, additional, Cavero-Redondo, Iván, additional, Challande, Pascal, additional, Chirinos, Julio A., additional, Climie, Rachel Emma, additional, Cockcroft, John, additional, Cotter, Jorge, additional, Cruickshank, J. Kennedy, additional, Cunha, Pedro Guimarães, additional, Damianaki, Aikaterini, additional, De Backer, Tine, additional, De Buyzere, Marc L., additional, De Caterina, Raffaele, additional, De Ciuceis, Carolina, additional, Debette, Stephanie, additional, Edsfeldt, Andreas, additional, Fernhall, Bo, additional, Ferreira, Isabel, additional, Fisher, Simon, additional, Forcada, Pedro, additional, S. Franklin, Stanley, additional, Garcia, Ricardo, additional, Georgiopoulos, Georgios, additional, Ghiadoni, Lorenzo, additional, Goncalves, Isabel, additional, Gottsäter, Mikael, additional, Graham, Delyth, additional, Greene, Katherine, additional, Guala, Andrea, additional, Hametner, Bernhard, additional, Hashimoto, Junichiro, additional, Hering, Dagmara, additional, Hibner, Brooks A., additional, Højlund, Kurt, additional, Hughes, Alun, additional, Ikonomidis, Ignatios, additional, Johansson, Madeleine, additional, Jordan, Jens, additional, Kario, Kazuomi, additional, Kotsis, Vasilios, additional, Kozakova, Michaela, additional, Lacolley, Patrick, additional, Lagrange, Jérémy, additional, Lakatta, Edward G., additional, Lambrinoudaki, Irene, additional, Laucyte-Cibulskiene, Agne, additional, Laurent, Stéphane, additional, Lopes, Wendell Arthur, additional, Lopez-Jaramillo, Patricio, additional, Magalhaes, Lucélia Batista Neves Cunha, additional, Magnussen, Costan G., additional, Mavraganis, Georgios, additional, Mayer, Christopher Clemens, additional, Maynard, Hannah, additional, McBride, Martin W., additional, McDonnell, Barry J., additional, McEniery, Carmel M., additional, Mota, Jorge, additional, Motl, Robert W., additional, Mozos, Ioana, additional, Muiesan, Maria Lorenza, additional, Muñoz, Ernesto Cardona, additional, Narkiewicz, Krzysztof, additional, Nemcsik, János, additional, Neves, Mario Fritsch, additional, Nilsson, Jan, additional, Nilsson, Peter M., additional, Oberhoffer-Fritz, Renate, additional, Ochoa, Juan Eugenio, additional, Okawa, Jaqueline Lyrio Bermudes, additional, Okawa, Rogério Toshiro Passos, additional, Olesen, Thomas Bastholm, additional, Oliveira, José, additional, Oliveras, Anna, additional, Hecht Olsen, Michael, additional, Ortiz, Luis Garcia, additional, Pahkala, Katja, additional, Paini, Anna, additional, Palombo, Carlo, additional, Parati, Gianfranco, additional, Park, Chloe, additional, Pavlidis, George, additional, Piani, Federica, additional, Pierce, Gary L., additional, Pizzala, Pablo G., additional, Protogerou, Athanase D., additional, Pucci, Giacomo, additional, Pupi, Luis María, additional, Pupi, Pablo María, additional, Raitakari, Olli T., additional, Rajkumar, C., additional, Ramirez, Agustín, additional, Raso, Francesco Mattace, additional, Recchia, Fabio Anastasio, additional, Regnault, Veronique, additional, Rietzschel, Ernst, additional, Rizzoni, Damiano, additional, Rodilla, Enrique, additional, Rovio, Suvi P., additional, Ryliskyte, Ligita, additional, Salvi, Paolo, additional, Sanchez, Ramiro, additional, Sáry, Javier Osvaldo, additional, Schillaci, Giuseppe, additional, Schmidt-Trucksäss, Arno, additional, Scuteri, Angelo, additional, Segers, Patrick, additional, Sharman, James, additional, Sierra, Cristina, additional, Stamatelopoulos, Kimon, additional, Steckelings, Ulrike M., additional, Stehouwer, Coen D.A., additional, Stoner, Lee, additional, Taddei, Stefano, additional, Terentes-Printzios, Dimitrios, additional, Tomiyama, Hirofumi, additional, Trivett, Cara, additional, Tsioufis, Costas, additional, Turroni, Silvia, additional, Urbina, Elaine M., additional, Van Bortel, L., additional, van de Laar, Roel J., additional, van der Heide, Frank C.T., additional, Vázquez, Susana, additional, Vishram-Nielsen, Julie, additional, Vlachopoulos, Charalambos, additional, Vlastos, Dimitrios, additional, Walker, Ashley, additional, Wang, Mingyi, additional, Weber, Thomas, additional, Xaplanteris, Panagiotis, additional, Zanoli, Luca, additional, and Zhou, Manshi, additional

Published
2024
Full Text
View/download PDF

5. e. Network for Research in Vascular Aging

Author

Mayer, Christopher Clemens, primary, Alastruey, Jordi, additional, Bruno, Rosa Maria, additional, Climie, Rachel Emma, additional, Guala, Andrea, additional, Hametner, Bernhard, additional, Mozos, Ioana, additional, Park, Chloe, additional, Pucci, Giacomo, additional, Terentes-Printzios, Dimitrios, additional, and Bianchini, Elisabetta, additional

Published
2024
Full Text
View/download PDF

6. Developing technologies to assess vascular ageing: a roadmap from VascAgeNet

Author

Zanelli, Serena, primary, Agnoletti, Davide, additional, Alastruey, Jordi, additional, Allen, John, additional, Bianchini, Elisabetta, additional, Bikia, Vasiliki, additional, Boutouyrie, Pierre, additional, Bruno, Rosa Maria, additional, Climie, Rachel, additional, Djamaleddine, Djeldjli, additional, Gkaliagkousi, Eugenia, additional, Giudici, Alessandro, additional, Gopcevic, Kristina, additional, Grillo, Andrea, additional, Guala, Andrea, additional, Hametner, Bernhard, additional, Joseph, Jayaraj, additional, Karimpour, Parmis, additional, Kodithuwakku, Vimarsha, additional, Kyriacou, Panayiotis A, additional, Lazaridis, Antonios, additional, Lonnebakken, Mai Tone, additional, Martina, Maria Raffaella, additional, Mayer, Christopher Clemens, additional, Nabeel, P M, additional, Navickas, Petras, additional, Nemcsik, Janos, additional, Orter, Stefan, additional, Park, Chloe, additional, Pereira, Telmo, additional, Pucci, Giacomo, additional, Amado Rey, Ana Belen, additional, Salvi, Paolo, additional, Gonçalves Seabra, Ana Carolina, additional, Seeland, Ute, additional, van Sloten, Thomas, additional, Spronck, Bart, additional, Stansby, Gerard, additional, Steens, Indra, additional, Stieglitz, Thomas, additional, Tan, Isabella, additional, Veerasingam, Dave, additional, Wassertheurer, Siegfried, additional, Weber, Thomas, additional, Westerhof, Berend E, additional, and Charlton, Peter H, additional

Published
2024
Full Text
View/download PDF

7. Translational Science in Vascular Aging: From Bench to Bedside—Insights from a VascAgeNet Roundtable.

Author

Bianchini, Elisabetta, Roth, Lynn, Boutouyrie, Pierre, Badhwar, Smriti, Schwarz, Achim, Gemignani, Vincenzo, Bruno, Rosa Maria, Hametner, Bernhard, Park, Chloe, Pucci, Giacomo, Mozos, Ioana, Terentes-Printzios, Dimitrios, Climie, Rachel E., Guala, Andrea, Alastruey, Jordi, and Mayer, Christopher C.

Subjects
AGING, PHARMACOLOGY, MEDICAL equipment, MEDICAL software, CLINICAL trials
Abstract

Translating vascular aging research from bench to bedside presents both significant opportunities and challenges. This paper summarizes insights from a roundtable discussion at the Artery 23 conference, featuring perspectives from basic science, clinical trials, regulation, and industry. The main conclusions of the discussion are as follows: basic science research must align with clinical relevance, using appropriate animal models and standardized measurement techniques. Pragmatic and registry-based clinical trials offer viable alternatives to traditional randomized controlled trials, facilitating real-world applicability. The regulatory landscape, particularly for software medical devices, must evolve to keep pace with technological advancements like artificial intelligence. Industry efforts focus on developing devices or solutions for vascular aging assessment and treatment strategies, yet face hurdles in large-scale adoption and reimbursement. Despite significant progress, the development of pharmacological interventions to mitigate vascular aging remains a critical need. This discussion underscores the importance of interdisciplinary collaboration to overcome barriers and translate scientific discoveries into clinical practice effectively. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. DIAGNOSTIC ACCURACY OF ATTENDED AND UNATTENDED BLOOD PRESSURE MEASUREMENTS IN PATIENTS WITH ARTERIAL HYPERTENSION

Author

Mancusi, C, Maloberti, A, Fucile, I, Manzi, M, Pengo, M, Bertacchini, F, Monticone, S, Pucci, G, Mancusi, Costantino, Maloberti, Alessandro, Fucile, Ilaria, Manzi, Maria Virigina, Pengo, Martino, Bertacchini, Fabio, Monticone, Silvia, Pucci, Giacomo, Mancusi, C, Maloberti, A, Fucile, I, Manzi, M, Pengo, M, Bertacchini, F, Monticone, S, Pucci, G, Mancusi, Costantino, Maloberti, Alessandro, Fucile, Ilaria, Manzi, Maria Virigina, Pengo, Martino, Bertacchini, Fabio, Monticone, Silvia, and Pucci, Giacomo

Published
2024

11. Atrial Fibrillation and Early Vascular Aging: Clinical Implications, Methodology Issues and Open Questions—A Review from the VascAgeNet COST Action

Author

Pucci, Giacomo, primary, Grillo, Andrea, additional, Dalakleidi, Kalliopi V., additional, Fraenkel, Emil, additional, Gkaliagkousi, Eugenia, additional, Golemati, Spyretta, additional, Guala, Andrea, additional, Hametner, Bernhard, additional, Lazaridis, Antonios, additional, Mayer, Christopher C., additional, Mozos, Ioana, additional, Pereira, Telmo, additional, Veerasingam, Dave, additional, Terentes-Printzios, Dimitrios, additional, and Agnoletti, Davide, additional

Published
2024
Full Text
View/download PDF

13. HYPERTENSION PHENOTYPES BASED ON BRACHIAL AND AORTIC 24HR SYSTOLIC PRESSURE AND THEIR ASSOCIATION WITH HYPERTENSION PHENOTYPES BASED ON BOTH BRACHIAL AND AORTIC 24HR SYSTOLIC PRESSURE AND THEIR ASSOCIATION WITH LEFT VENTRICULAR HYPERTROPHY: FINDINGS FROM THE I24ABC CONSORTIUM

Author

Athanasopoulou, Elpida, Weber, Thomas, Wassertheurer, Siegfried, Sharman, James E., Argyris, Antonios, Sala, Enrique Rodilla, Jankowski, Piotr, Muiesan, Maria Lorenza, Giannattasio, Cristina, Wilkinson, Ian, Hametner, Bernhard, Orter, Stefan, Mayer, Christopher, Li, Yan, Pascual, Jose Maria, Danninger, Kathrin, Karachalias, Fotis, McEniery, Carmel, Pucci, Giacomo, and Blacher, Jaques

Published
2024
Full Text
View/download PDF

16. Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire.

Author

Halimi JM, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, Camafort M, Chapman N, Cottone S, de Backer T, Deinum J, Delmotte P, Dorobantu M, Doumas M, Dusing R, Duly-Bouhanick B, Fauvel JP, Fesler P, Gaciong Z, Gkaliagkousi E, Gordin D, Grassi G, Grassos C, Guerrot D, Huart J, Izzo R, Águila FJ, Járai Z, Kahan T, Kantola I, Kociánová E, Limbourg FP, Lopez-Sublet M, Mallamaci F, Manolis A, Marketou M, Mayer G, Mazza A, MacIntyre IM, Mourad JJ, Muiesan ML, Nasr E, Nilsson P, Oliveras A, Ormezzano O, Paixão-Dias V, Papadakis I, Papadopoulos D, Perl S, Polónia J, Pontremoli R, Pucci G, Robles NR, Rubin S, Ruilope LM, Rump LC, Saeed S, Sanidas E, Sarzani R, Schmieder R, Silhol F, Sokolovic S, Solbu M, Soucek M, Stergiou G, Sudano I, Tabbalat R, Tengiz I, Triantafyllidi H, Tsioufis K, Václavík J, van der Giet M, Van der Niepen P, Veglio F, Venzin RM, Viigimaa M, Weber T, Widimsky J, Wuerzner G, Zelveian P, Zebekakis P, Lueders S, Persu A, Kreutz R, and Vogt L

Subjects
Humans, Surveys and Questionnaires, Male, Female, Pilot Projects, Referral and Consultation, Antihypertensive Agents therapeutic use, Middle Aged, Mass Screening methods, Europe, Aged, Glomerular Filtration Rate, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic physiopathology, Hypertension drug therapy, Hypertension complications
Abstract

Objective: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear., Methods: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management of CKD patients referred to ESH-Hypertension Excellence Centres (ESH-ECs) at first referral visit. The questionnaire contained 64 questions with which ESH-ECs representatives were asked to estimate preexisting CKD management quality., Results: Overall, 88 ESH-ECs from 27 countries participated (fully completed surveys: 66/88 [75.0%]). ESH-ECs reported that 28% (median, interquartile range: 15-50%) had preexisting CKD, with 10% of them (5-30%) previously referred to a nephrologist, while 30% (15-40%) had resistant hypertension. The reported rate of previous recent (<6 months) estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (UACR) testing were 80% (50-95%) and 30% (15-50%), respectively. The reported use of renin-angiotensin system blockers was 80% (70-90%). When a nephrologist was part of the ESH-EC teams the reported rates SGLT2 inhibitors (27.5% [20-40%] vs. 15% [10-25], P  = 0.003), GLP1-RA (10% [10-20%] vs. 5% [5-10%], P  = 0.003) and mineralocorticoid receptor antagonists (20% [10-30%] vs. 15% [10-20%], P  = 0.05) use were greater as compared to ESH-ECs without nephrologist participation. The rate of reported resistant hypertension, recent eGFR and UACR results and management of CKD patients prior to referral varied widely across countries., Conclusions: Our estimation indicates deficits regarding CKD screening, use of nephroprotective drugs and referral to nephrologists before referral to ESH-ECs but results varied widely across countries. This information can be used to build specific programs to improve care in hypertensives with CKD., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results